Prevalence of Antiretroviral Drug Resistance Mutations in HIV Seropositive Patients from an Outpatient Clinic of a Large University Hospital from São Paulo, Brazil-Reference-Cited by-同舟云学术

Prevalence of Antiretroviral Drug Resistance Mutations in HIV Seropositive Patients from an Outpatient Clinic of a Large University Hospital from São Paulo, Brazil

Published:2020-03-01 Issue:3 Volume:36 Page:200-204
ISSN:0889-2229
Container-title:AIDS Research and Human Retroviruses
language:en
Short-container-title:AIDS Research and Human Retroviruses

Author:

Oliveira Constantinov Ericka¹,Brígido Luís Fernando de Macedo²,Fonseca Luiz Augusto M.³,Casseb Jorge¹⁴,Veiga Ana Paula R.,Magri Marcello M. C.,Monteiro Mariana A.,Rocha Rosana C.,Gascon Maria R. P.,Ferreira Mauricio D.,Polis Thales J. B.,de Lima Nascimento Najara A.,Limongelli Isadora Id,Oliveira Ícaro S.,Duarte Alberto J. S.,

Affiliation:

1. Department of Dermatology and Immunodeficiencies (LIM-56), Institute of Tropical Medicine of São Paulo, University of São Paulo, São Paulo, Brazil.

2. Division of Blood and Sexual Diseases-Retrovirus Laboratory, Department of Virology, Adolfo Lutz Institute, São Paulo, Brazil.

3. Department of Preventive Medicine, University of São Paulo, São Paulo, Brazil.

4. HIV Outpatient Service of the Secondary Immunodeficiencies Clinic (ADEE 3002), University of São Paulo, Hospital das Clinicas, São Paulo, Brazil.

Publisher

Mary Ann Liebert Inc

Subject

Infectious Diseases,Virology,Immunology

Link

https://www.liebertpub.com/doi/pdf/10.1089/aid.2019.0151

Reference22 articles.

1. Current Approaches in Computational Drug Resistance Prediction in HIV

2. Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study

3. 4. HIV drug resistance report 2017. Geneva: World Health Organization; 2017.

4. Commonly Transmitted HIV-1 Drug Resistance Mutations in Reverse-Transcriptase and Protease in Antiretroviral Treatment–Naive Patients and Response to Regimens Containing Tenofovir Disoproxil Fumarate or Tenofovir Alafenamide

5. Response to Therapy in Antiretroviral Therapy–Naive Patients With Isolated Nonnucleoside Reverse Transcriptase Inhibitor–Associated Transmitted Drug Resistance